- Home
- GTE vs FBRX Comparison
GTE vs FBRX Comparison
Compare GTE & FBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GTE | FBRX |
|---|---|---|
| Founded | 2003 | N/A |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 158.1M | 170.0M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | GTE | FBRX |
|---|---|---|
| Price | $4.71 | $19.93 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $67.00 |
| AVG Volume (30 Days) | ★ 507.5K | 112.8K |
| Earning Date | 10-30-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $611,444,000.00 | N/A |
| Revenue This Year | $4.87 | N/A |
| Revenue Next Year | $1.50 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.09 | $4.90 |
| 52 Week High | $8.19 | $28.68 |
Technical Indicators
Market Signals| Indicator | GTE | FBRX |
|---|---|---|
| Relative Strength Index (RSI) | 61.65 | 63.36 |
| Support Level | $4.47 | $17.33 |
| Resistance Level | $4.81 | $19.22 |
| Average True Range (ATR) | 0.24 | 2.25 |
| MACD | 0.03 | 0.14 |
| Stochastic Oscillator | 80.00 | 72.49 |
Price Performance
Historical ComparisonAbout GTE Gran Tierra Energy Inc.
Gran Tierra Energy Inc is an independent energy company. The company, along with its subsidiaries, is focused on oil and gas exploration and production, with assets in Colombia, Canada, and Ecuador. It produces oil, natural gas, and natural gas liquids. Gran Tierra has assembled a diversified, high-quality asset base that is fully operated in Colombia and Ecuador and partly in Canada. The company operates various blocks in Colombia and Ecuador, spanning three basins. It also has contiguous areas in Alberta, Canada, spanning various gross acres across the Western Canadian Sedimentary Basin. The company's reportable segments are Colombia, Ecuador, Canada, and Other. A majority of its revenue is derived from its operations in Colombia.
About FBRX Forte Biosciences Inc.
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, alopecia areata, and type 1 diabetes (T1D).